The overall goal of the Cincinnati DDRDC: Center for Growth and Development (CGD) is to promote research that will yield insights into the fundamental processes of growth and development in the digestive tract and lead to novel or improved therapies. The specific goals of the CGD derive from the central theme that understanding the molecular mechanisms that control development of the gastrointestinal tract and liver will result in strategies to correct intestinal, nutritional and liver disease. Furthermore, our working model of interdisciplinary collaboration and our strong research environment will continue to lead to productive investigation in digestive diseases. The 28 full members and 6 associate members come from 9 different divisions within the Department of Pediatrics and a total of 6 Departments within the University of Cincinnati College of Medicine. These investigators are grouped into four working areas that all impact growth and development: Differentiation, Absorption and Secretion, Inflammation, and Regeneration and Repair.
The Aims of the Cincinnati DDRDC:CGD are: 1) To promote research in basic and translational science areas relevant to understanding of gastrointestinal and liver growth and development, as well as digestive disease, by studying differentiation, absorption and secretion, inflammation, and regeneration and repair; 2) To promote interactions among scientists with diverse backgrounds, 3) To attract basic investigators to the study of gastrointestinal and liver growth and development, and 4) To foster translational research in digestive disease.
The specific aims of the Center will be achieved primarily through three inter-related Biomedical Research Cores. 1) The Microarray Core will perform high quality state of the art experiments to identify novel genes expressed in the digestive organs of humans and in animal models of disease. 2) The Bioinformatics Core will provide design assistance and statistical and computational analysis for the complex experiments performed in the Microarray Core. 3) The Integrative Morphology Core will provide consultation and technical support for morphology studies, including in situ hybridization to localize gene expression identified by microarray analysis. Thus, at many levels, there is strong synergy among the research base and among the Biomedical Research Cores. This synergy will increase efficiency, promote new research directions, and foster collaborations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Resource-Related Research Projects (R24)
Project #
5R24DK064403-02
Application #
6746904
Study Section
Special Emphasis Panel (ZDK1-GRB-6 (J1))
Program Officer
Podskalny, Judith M,
Project Start
2003-05-08
Project End
2008-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
2
Fiscal Year
2004
Total Cost
$518,000
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Kulkarni, Rishikesh M; Kutcher, Louis W; Stuart, William D et al. (2012) Ron receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failure. Hepatobiliary Pancreat Dis Int 11:383-92
Nikolaidis, Nikolaos M; Kulkarni, Rishikesh M; Gray, Jerilyn K et al. (2011) Ron receptor deficient alveolar myeloid cells exacerbate LPS-induced acute lung injury in the murine lung. Innate Immun 17:499-507
Stuart, William D; Kulkarni, Rishikesh M; Gray, Jerilyn K et al. (2011) Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice. Hepatology 53:1618-28
Meyer, Sara E; Peace, Belinda E; Bahassi, El Mustapha et al. (2010) Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice. Cancer Lett 296:186-93
Nikolaidis, Nikolaos M; Gray, Jerilyn K; Gurusamy, Devikala et al. (2010) Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production. Shock 33:197-204
Pentiuk, Scott; Putnam, Phillip E; Collins, Margaret H et al. (2009) Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 48:152-60
Meyer, Sara E; Zinser, Glendon M; Stuart, William D et al. (2009) The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis. Dev Biol 333:173-85
Carey, Rebecca; Jurickova, Ingrid; Ballard, Edgar et al. (2008) Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease. Inflamm Bowel Dis 14:446-57
Caldwell, Charles C; Martignoni, Andre; Leonis, Mike A et al. (2008) Ron receptor tyrosine kinase-dependent hepatic neutrophil recruitment and survival benefit in a murine model of bacterial peritonitis. Crit Care Med 36:1585-93
Martin, Colin A; Bernabe, Kathryn Q; Taylor, Janice A et al. (2008) Resection-induced intestinal adaptation and the role of enteric smooth muscle. J Pediatr Surg 43:1011-7

Showing the most recent 10 out of 47 publications